Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zenas BioPharma (ZBIO) Prepaid Assets (2023 - 2025)

Zenas BioPharma (ZBIO) has 3 years of Prepaid Assets data on record, last reported at $5.8 million in Q3 2025.

  • For Q3 2025, Prepaid Assets fell 17.5% year-over-year to $5.8 million; the TTM value through Sep 2025 reached $5.8 million, down 17.5%, while the annual FY2024 figure was $5.1 million, 71.94% up from the prior year.
  • Prepaid Assets reached $5.8 million in Q3 2025 per ZBIO's latest filing, up from $5.3 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $7.0 million in Q3 2024 and bottomed at $2.9 million in Q4 2023.
  • Average Prepaid Assets over 3 years is $5.3 million, with a median of $5.4 million recorded in 2025.
  • Peak YoY movement for Prepaid Assets: surged 71.94% in 2024, then decreased 17.5% in 2025.
  • A 3-year view of Prepaid Assets shows it stood at $2.9 million in 2023, then soared by 71.94% to $5.1 million in 2024, then grew by 13.64% to $5.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $5.8 million in Q3 2025, $5.3 million in Q2 2025, and $5.4 million in Q1 2025.